- Home
- DH vs CYRX Comparison
DH vs CYRX Comparison
Compare DH & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DH
- CYRX
- Stock Information
- Founded
- DH 2011
- CYRX 1999
- Country
- DH United States
- CYRX United States
- Employees
- DH N/A
- CYRX N/A
- Industry
- DH Computer Software: Prepackaged Software
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- DH Technology
- CYRX Health Care
- Exchange
- DH Nasdaq
- CYRX Nasdaq
- Market Cap
- DH 310.5M
- CYRX 310.4M
- IPO Year
- DH 2021
- CYRX N/A
- Fundamental
- Price
- DH $2.79
- CYRX $6.10
- Analyst Decision
- DH Hold
- CYRX Strong Buy
- Analyst Count
- DH 11
- CYRX 6
- Target Price
- DH $5.35
- CYRX $11.50
- AVG Volume (30 Days)
- DH 986.1K
- CYRX 694.8K
- Earning Date
- DH 05-06-2025
- CYRX 05-06-2025
- Dividend Yield
- DH N/A
- CYRX N/A
- EPS Growth
- DH N/A
- CYRX N/A
- EPS
- DH N/A
- CYRX N/A
- Revenue
- DH $252,202,000.00
- CYRX $228,385,000.00
- Revenue This Year
- DH N/A
- CYRX $9.18
- Revenue Next Year
- DH $3.26
- CYRX $8.65
- P/E Ratio
- DH N/A
- CYRX N/A
- Revenue Growth
- DH 0.31
- CYRX N/A
- 52 Week Low
- DH $2.54
- CYRX $4.58
- 52 Week High
- DH $8.33
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- DH 36.94
- CYRX 48.98
- Support Level
- DH $2.87
- CYRX $5.90
- Resistance Level
- DH $2.99
- CYRX $7.00
- Average True Range (ATR)
- DH 0.17
- CYRX 0.56
- MACD
- DH 0.07
- CYRX 0.03
- Stochastic Oscillator
- DH 47.62
- CYRX 41.18
About DH Definitive Healthcare Corp.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.